GSK’s Horlicks Review Plan - Some Early Expectations In India

A potential sale of Horlicks could impact market dynamics significantly in India where the popular malt beverage holds a dominant position but has seen competition build up. GlaxoSmithKline, though, has underscored that the review plan had nothing to do with the product’s "critical mass".

Leadership
A POTENTIAL SALE OF HORLICKS COULD IMPACT MARKET DYNAMICS IN INDIA

More from Business

More from Scrip